Agenus (AGEN) - Management Comments

Agenus (AGEN) – Management Comments

Apr 19, 2021 08:35 AM Agenus (AGEN) Reports Biologics License Application Submission to FDA for Patients with Recurrent or Metastatic Cervical Cancer
Feb 9, 2021 08:46 AM Agenus (AGEN) announced additional confirmed objective clinical responses from its Phase 1/2 trial of AGEN1181
Dec 1, 2020 08:08 AM
Nov 19, 2020 08:04 AM
Jun 22, 2020 07:04 AM
Jun 2, 2020 08:31 AM
Jan 9, 2020 11:01 AM
Nov 11, 2019 08:03 AM
Nov 4, 2019 07:08 AM
Sep 10, 2019 07:02 AM
Aug 8, 2019 07:42 AM
May 9, 2019 07:42 AM
Apr 2, 2019 08:34 AM
Mar 27, 2019 09:04 AM
Mar 14, 2019 08:07 AM
Mar 13, 2019 08:34 AM
Dec 20, 2018 08:28 AM
Oct 22, 2018 06:21 AM
Sep 21, 2018 07:04 AM
Sep 21, 2018 07:01 AM
Sep 17, 2018 09:03 AM
Aug 15, 2018 01:29 PM
Jun 4, 2018 01:38 PM
May 7, 2018 09:03 AM
Jan 22, 2018 10:33 AM
Jan 8, 2018 08:39 AM
Nov 15, 2017 09:28 AM
Oct 25, 2017 04:25 PM
Oct 23, 2017 05:44 AM
Sep 13, 2017 03:51 PM
Jun 21, 2017 09:30 AM
Mar 30, 2017 06:50 AM
Feb 14, 2017 07:07 AM
Jan 30, 2017 09:01 AM
Nov 30, 2016 08:53 AM
Oct 24, 2016 07:30 AM
Sep 14, 2016 05:42 PM
Jun 22, 2016 08:51 AM
Apr 27, 2016 08:50 AM
Jan 21, 2016 08:00 AM
Jan 4, 2016 07:06 AM
Dec 23, 2015 04:02 PM
Nov 5, 2015 04:11 PM
Oct 27, 2015 06:56 AM
Jul 24, 2015 06:00 AM
Jun 17, 2015 07:03 AM
Jun 3, 2015 07:02 AM
Jun 1, 2015 07:01 AM
May 14, 2015 07:20 AM
Apr 28, 2015 08:07 AM